Multiple Strength GS-441524 Tablets 20mg 40mg 50mg 60mg Oral Formula for Cat FIP Veterinary Use

Product Introduction

GS-441524 tablets are developed for veterinary use in feline infectious peritonitis (FIP) management programs. As oral antiviral formulations become increasingly adopted in feline healthcare, tablets provide a practical option for daily administration during extended treatment plans.

To accommodate different body weights and treatment requirements, the tablets are available in 20mg, 40mg, 50mg, and 60mg strengths.

Multiple strength options allow veterinarians and caregivers to select an appropriate dosage plan while reducing the need to divide tablets or administer excessive quantities during treatment.

Compared with injectable formulations, oral tablets are often chosen when convenient daily administration is preferred. They are especially suitable for cats that have become stable during treatment or for caregivers looking for an easier method of long-term antiviral support.

Each production batch is manufactured under standardized quality management procedures to help maintain product consistency, tablet uniformity, and reliable stability throughout storage and transportation.

Product Highlights

Multiple Strength Options

Four tablet strengths are available to support different treatment requirements:

• 20mg – Suitable for kittens, smaller cats, or flexible dose adjustments.
• 40mg – A commonly selected strength for routine weight-based treatment plans.
• 50mg – Designed for cats requiring higher daily antiviral support while reducing tablet quantity.
• 60mg – A high-strength option that helps simplify dosing for larger cats or advanced treatment protocols.

Providing multiple strengths makes it easier to develop individualized treatment plans according to body weight and veterinary recommendations.

Convenient Oral Administration

The tablet formulation offers a simple alternative to injectable products. Daily oral administration may reduce stress for both caregivers and cats during extended treatment cycles.

Reliable Manufacturing Standards

Production is carried out using controlled manufacturing processes, with quality inspections performed throughout each stage to support consistent tablet quality and batch-to-batch reliability.

Stable Product Performance

Careful formulation and packaging help maintain product stability during transportation and storage, making the tablets suitable for domestic use as well as international distribution.

About Feline Infectious Peritonitis

Feline infectious peritonitis is a progressive viral disease caused by mutations of feline coronavirus. Although feline coronavirus is common in cat populations, only a small percentage of infected cats develop FIP.

The disease may present in several clinical forms, including:

• Wet (Effusive) FIP, often accompanied by fluid accumulation in the abdomen or chest.
• Dry (Non-Effusive) FIP, which primarily affects internal organs.
• Ocular FIP, involving inflammation of the eyes.
• Neurological FIP, affecting the brain and nervous system.

Because clinical signs and disease progression differ between patients, treatment plans should always be based on veterinary assessment and regular monitoring.

Application Scenarios

GS-441524 tablets are suitable for a wide range of veterinary and animal care settings, including:

• Veterinary clinics
• Animal hospitals
• Cat rescue organizations
• Professional breeding facilities
• Veterinary pharmaceutical distributors
• Home care under veterinary supervision

The availability of multiple tablet strengths allows greater flexibility when developing individualized treatment programs.

Storage Guidelines

To maintain product quality, the tablets should be stored under appropriate conditions:

• Store at room temperature in a clean and dry location.
• Keep the original packaging tightly sealed after opening.
• Protect from moisture, direct sunlight, and excessive heat.
• Store out of reach of children and animals when not in use.

Proper storage helps preserve product quality throughout its shelf life.

Quality Commitment

Every production batch undergoes standardized quality management procedures before packaging and shipment. From raw material selection to finished product inspection, attention is given to consistency, stability, and traceability.

With multiple strength options, reliable manufacturing standards, and convenient oral administration, GS-441524 tablets are supplied to veterinary professionals and feline healthcare providers seeking flexible solutions for FIP management programs.

Important Notice

This product is intended for veterinary use only.

Treatment protocols, dosage selection, and administration schedules should always be determined by a qualified veterinarian according to the cat's body weight, clinical condition, and ongoing response to treatment.